The Market Reports

Synopsis
The global market for Frozen Tissues Samples was estimated to be worth US$ 68.9 million in 2024 and is forecast to a readjusted size of US$ 197 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.
Frozen tissues, on the other hand, work very well for molecular genetic analysis – especially if the biopsy materials are dipped in liquid nitrogen in a method called “flash freezing,” and then stored in an ultra-cold freezer at less than -80 degrees Celsius. Thus, if you have a “-80” freezer and liquid nitrogen, fresh frozen tissues are easy to prepare. Frozen tissue array samples are also very useful for IHC analysis, since proteins are preserved in a native state.
The global frozen tissue samples market is experiencing steady growth, driven primarily by the increasing demand for precision medicine, cancer research, and biomarker discovery. As researchers and pharmaceutical companies seek higher-quality biospecimens for genomic, proteomic, and histological analyses, frozen tissue samples have become crucial due to their ability to preserve molecular integrity. The growing prevalence of chronic diseases—especially cancer—has intensified the need for biobanked tissue samples to support drug development and personalized treatment strategies. Furthermore, advancements in biobanking infrastructure, coupled with increased investment in life sciences research, have enabled the collection, storage, and distribution of high-quality frozen specimens on a global scale. Government initiatives and public-private partnerships in biomedical research are also playing a significant role in market expansion.
Despite growing demand, the frozen tissue samples market faces several challenges. One of the major issues is the complexity of sample collection, transportation, and storage, which requires strict adherence to cold chain logistics and quality control standards to maintain sample viability. High costs associated with cryopreservation and long-term storage can be a barrier for small research institutions and low-income countries. Additionally, ethical concerns and regulatory hurdles related to patient consent, sample usage rights, and international biobanking laws can complicate cross-border collaborations. There is also a lack of standardization in sample processing and data annotation, which affects reproducibility and limits the comparability of research outcomes. These factors collectively pose challenges to the scalability and accessibility of high-quality frozen tissue biobanks.
Global major companies profiled in the Frozen Tissues Samples market include Precision for Medicine, ProteoGenex, Bay BioSciences, Zen-Bio, OriGene Technologies, etc. Global top five companies account for nearly 25% of market share. North America is the largest market and accounts for over 45 percent. Besides, Europe and Asia-Pacific are likely to offer good prospects, have a share about 25% and 20% respectively. In terms of product, Frozen Tumor Tissue Samples is the largest segment, with a share over 65%. And based on application, the largest application is Cancer Research, followed by Disease Diagnosis and so on.
This report aims to provide a comprehensive presentation of the global market for Frozen Tissues Samples, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Frozen Tissues Samples by region & country, by Type, and by Application.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Frozen Tissues Samples cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Frozen Tissues Samples market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frozen Tissues Samples.
Market Segmentation
By Company
Precision for Medicine
ProteoGenex
Bay BioSciences
Zen-Bio
OriGene Technologies
AMS Biotechnology (Europe)
REPROCELL
US Biolab Corporation
BioChain Institute
Geneticist
Segment by Type
Frozen Normal Tissue Samples
Frozen Tumor Tissue Samples
Others
Segment by Application
Cancer Research
Disease Diagnosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Frozen Tissues Samples manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Frozen Tissues Samples in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Frozen Tissues Samples in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index